The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

Omnicare Inc

NYSE: OCR
Last

(U.S.) $95.59

Today's change+0.28 +0.29%
Updated July 28 11:36 AM EDT. Delayed by at least 15 minutes.
 

Omnicare Inc

NYSE: OCR
Last

(U.S.) $95.59

Today's change+0.28 +0.29%
Updated July 28 11:36 AM EDT. Delayed by at least 15 minutes.

Omnicare Inc up (U.S.)$0.28

Omnicare Inc is up today by (U.S.)$0.28 or 0.29% to (U.S.)$95.59. Over the last five days, shares are unchanged, but have gained 31.07% over the last year to date. This security has outperformed the S&P 500 by 44.47% during the last year.

Key company metrics

  • Open(U.S.) $95.46
  • Previous close(U.S.) $95.31
  • High(U.S.) $95.75
  • Low(U.S.) $95.33
  • Bid / Ask(U.S.) $95.58 / (U.S.) $95.60
  • YTD % change+31.07%
  • Volume491,167
  • Average volume (10-day)1,168,690
  • Average volume (1-month)1,452,535
  • Average volume (3-month)2,592,209
  • 52-week range(U.S.) $59.85 to (U.S.) $96.54
  • Beta1.31
  • Trailing P/E50.74×
  • P/E 1 year forward23.56×
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend(U.S.) $0.88
  • Dividend yield0.92%
  • Trailing EPS(U.S.) $1.88
Updated July 28 11:36 AM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+2.57%

Based on its net profit margin of 2.57%, Omnicare Inc is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.21%Sector:HealthcareIndustry:Healthcare Facilities
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2015Q1/2015Q4/2014Q3/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201506/30/2015Mar 31, 201503/31/2015Dec 31, 201412/31/2014Sep 30, 201409/30/2014
Revenue1,7331,6601,6281,608
Total other revenue--------
Total revenue1,7331,6601,6281,608
Gross profit354349354351
Total cost of revenue1,3791,3101,2741,257
Total operating expense1,6361,5081,5991,472
Selling / general / administrative188187197199
Research & development--------
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)58116917
Other operating expenses, total11--60--
Operating income9715229136
Interest income (expense), net non-operating-27-28-42-29
Gain (loss) on sale of assets--------
Other--------
Income before tax70124-13107
Income after tax3477-968
Income tax, total3647-439
Net income3477-665
Total adjustments to net income--------
Net income before extra. items3477-968
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items3477-968
Inc. avail. to common incl. extra. items3477-665
Diluted net income3477-665
Dilution adjustment----00
Diluted weighted average shares10510398106
Diluted EPS excluding extraordinary itemsvalue per share0.320.75-0.090.65
Dividends per sharevalue per share0.220.220.220.20
Diluted normalized EPSvalue per share0.590.820.370.75